The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
about
Assessment of Equine Autoimmune Thrombocytopenia (EAT) by flow cytometryFetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and PreventionAspirin resistance: an evaluation of current evidence and measurement methodsCommon variations in platelet glycoproteins: pharmacogenomic implicationsPlatelet alphaIIbbeta3 recombinant autoantibodies from the B-cell repertoire of a post-transfusion purpura patient.Rapid phenotyping of HPA-1a using either diabody-based hemagglutination or recombinant IgG1-based assays.A rapid one-stage whole-blood HPA-1a phenotyping assay using a recombinant monoclonal IgG1 anti-HPA-1a.Prenatal intracranial hemorrhage and neurologic complications in alloimmune thrombocytopenia.Rapid and reliable genotyping of human platelet antigen (HPA)-1, -2, -3, -4, and -5 a/b and Gov a/b by melting curve analysis.Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy.Molecular biology for platelet alloantigen typing.Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism.Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIAFlanking p10 contribution and sequence bias in matrix based epitope prediction: revisiting the assumption of independent binding pocketsThe GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia.Studies on the HLA Class-II Antigens of a Patient Presenting a Double Alloimmunization Following Posttransfusion Purpura.Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads.New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopeniaThe development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.Modeling and molecular dynamics of HPA-1a and -1b polymorphisms: effects on the structure of the β3 subunit of the αIIbβ3 integrin.Genetic variability in platelet integrin α2β1 density: possible contributor to Plasmodium vivax-induced severe thrombocytopenia.Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management.Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.Polymorphisms in canine platelet glycoproteins identify potential platelet antigensHuman platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.Noninvasive fetal genotyping of human platelet antigen-1a using targeted massively parallel sequencing.Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia.CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypesAntiendothelial αvβ3 Antibodies Are a Major Cause of Intracranial Bleeding in Fetal/Neonatal Alloimmune ThrombocytopeniaT cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition.HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopeniaAllele frequencies of the human platelet antigen-1 in the Egyptian populationHuman platelet antigen-1 (Zw) typing of fetuses by analysis of polymerase chain reaction-amplified genomic DNA from amniocytes.Human platelet antigen-1 (Zw) typing using PCR-RFLP.Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia.Human platelet-specific alloantigens: update.
P2860
Q24798317-A67137C3-E15F-4889-823F-1218BED8EC24Q26777281-A8488E66-1C63-4552-A843-0E8B4178C1C9Q28183220-619776AA-4035-4FD3-B92E-ED4E0D6DD0F5Q28191774-E9519E1F-E8A1-4A66-BD07-9E8627169777Q30724883-BC402FE2-BBFC-4D30-B006-F45F86DFA801Q33329519-7C8C2CE8-36AC-43F9-B1D4-E35C62BC96ADQ33331591-660CE441-EAAE-4982-B85E-CA944A2C72DEQ33340058-E6CD8D47-E3F1-468E-8CE8-9DB2EF115E10Q33347179-52832563-714B-43CA-A49F-08AE644D9C4CQ33351609-C1066EC6-50F0-4787-A4CC-E7054DF97C70Q33352633-E42B4DE7-40E5-456D-8BA0-C5A69B8CA65CQ33368580-A8A41D0B-1905-4706-9BD9-CAE6506E45AFQ33377139-514E9172-AB18-4DB2-A022-F8386F91ED44Q33377255-AAF40BEE-255B-4CF5-BA28-F8E38F2158AEQ33381441-833179EA-0722-4A5D-992E-E3372EDA8D59Q33381967-433D258A-AF11-424C-8F15-8263FF1851D6Q33392621-65415753-4D48-4861-AC1A-B1732F2D7D15Q33392862-39884BBF-CD87-423C-A0CA-AF59299AB994Q33393340-0995B74E-6D57-4322-97BC-D6116D9120CDQ33398132-8106AB32-324D-463B-B1A7-D13869A81714Q33398407-54B6E419-0EBD-4AC0-BB80-F17BCD26D16BQ33401637-009F8D52-F551-48A7-B9D5-D0AAC6DB6D1CQ33404386-F0BBBFA5-B26F-4A91-B1A2-C919BE36361BQ33404884-9BB87925-643C-4BF6-A6D4-4FD9E0066362Q33405694-6FD9D192-EB91-4BFA-AE6A-118D81745041Q33407728-8B60FB88-5BF6-4D2E-B811-E3C1D9C93603Q33411360-8F3CE39B-3E6F-406F-8451-8AC01938CD9FQ33411662-BC43F552-62F8-4DED-848B-F08872BEDC90Q33421975-9DD38C0A-9207-4848-857A-A5E795C4C510Q33425658-BDEB5B07-BF57-47C9-9F59-DA855D8C4830Q33428137-8EC7B581-76E1-4FD6-B6A9-E1DBE89C8517Q33432924-86DADAE7-EB26-48E1-ADF0-8DC291DFBABAQ33435753-40CD5A6D-56CE-402A-850B-D927A474672BQ33437901-26C34615-E6B7-4B71-9D3F-1109F1EF6A49Q33440427-658755D6-4349-44CF-8E84-A7FBEA4421ECQ33448997-F7BA921D-590F-4512-80C8-7A229B93BAC1Q33487895-6AFE1CD1-0E73-4806-9039-D7FC790A4991Q33492191-049097A4-A7F4-434C-931B-216F1999AB50Q33497352-1D4C45EA-0D36-4A5C-9873-9CB5EAB12838Q33503320-DA88714D-9B49-4AE3-AEBB-154F2FBBFF0F
P2860
The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
The human platelet alloantigen ...... distinguishable by DNA typing.
@ast
The human platelet alloantigen ...... distinguishable by DNA typing.
@en
The human platelet alloantigen ...... distinguishable by DNA typing.
@nl
type
label
The human platelet alloantigen ...... distinguishable by DNA typing.
@ast
The human platelet alloantigen ...... distinguishable by DNA typing.
@en
The human platelet alloantigen ...... distinguishable by DNA typing.
@nl
prefLabel
The human platelet alloantigen ...... distinguishable by DNA typing.
@ast
The human platelet alloantigen ...... distinguishable by DNA typing.
@en
The human platelet alloantigen ...... distinguishable by DNA typing.
@nl
P2093
P2860
P356
P1476
The human platelet alloantigen ...... distinguishable by DNA typing.
@en
P2093
P2860
P304
P356
10.1172/JCI114082
P407
P577
1989-05-01T00:00:00Z